Lorient

France

60 total trials 23 recruiting

Filter these 60 trials by phase, condition, sponsor and more.

Open in Search →

Phase III trial of laryngeal preservation comparating chemotherapy followed by radiotherapy to chemotherapy administrated during radiotherap … Ended recruitment

2024-513976-16-00 5 2015-06-26 squamous cell carcinomas of the larynx or hypopharynx locally advance
PRODIGE 34 - ADAGE: Randomised phase III study evaluating adjuvant chemotherapy after resection of stage III colon adenocarcinoma in patient … Ended recruitment

2024-518741-21-00 4 2014-12-23 colon cancer
A large-scale comparative study evaluating an intravenous treatment, cabazitaxel, and radiation therapy to the pelvic lymph nodes in patient … Ended recruitment

2024-517622-25-00 5 2013-12-06 Patients with localized prostate cancer and high-risk features of rela
Safety Study of Adding Everolimus to Adjuvant Hormone Therapy in Women With High Risk of Relapse, ER+ and HER2- Primary Breast Cancer, Free … Ended recruitment

2024-516198-61-00 5 2013-06-05 Patients with high risk of relapse, ER+ and HER2- primary non-metastat
A randomized, open-label, controlled phase III trial comparing the pembrolizumab platinum based chemotherapy combination with pembrolizumab … Ended

2024-513697-22-00 5 2024-11-07 non-small-cell lung cancer
GuARD: GR1014 cutaneous gel Against Radiation Dermatitis Ended

2023-508728-36-00 4 2024-07-26 Radiation-induced dermatitis (radiodermatitis)
Study comparing radiotherapy combined with cetuximab + Xevinapant (study drug) with radiotherapy combined with cetuximab + placebo in patien … Ended

2022-502584-38-00 5 2023-12-12 Locally advanced squamous cell carcinoma of the head and neck
Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab (AMG 451) in Combination with Topical Corticosteroids and/or Topical … Ended

2022-501585-22-00 5 2023-05-11 Atopic Dermatitis
Phase III Xevinapant (Debio 1143) and Radiotherapy in Resected LA SCCHN High Risk, Cisplatin-ineligible Participants (XRAY VISION) Ended

2023-508528-36-00 5 2022-12-16 Resected squamous cell carcinoma of the head and neck
Randomized trial evaluating adapted chemotherapy in patients with squamous carcinoma Ended

2024-512456-38-00 4 2021-02-04 locally advanced squamous cell carcinoma
Trial evaluating the tolerance and safety of durvalumab - radiotherapy combination for treatment of cancers of the head and neck Ended

2024-513977-31-00 4 2019-07-17 Untreated squamous cell carcinoma of the head and neck
Evaluation of Upadacitinib in Adolescent and Adult Patients with Moderate to Severe Atopic Dermatitis (Eczema) – Measure Up 2 Ended

2022-502936-38-00 5 2019-01-09 Moderate and Severe Atopic Dermatitis

Showing 49–60 of 60 trials